Murugesan Palaniappan1,2

  • 1Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

Biomedicines
|January 8, 2025
PubMed
概括

雌激素受体α (ERα) 突变驱动内分泌抵抗性乳腺癌. 针对这些ERα突变的新疗法对于治疗传统治疗失败的晚期转移性乳腺癌至关重要.